Loading…
avatar for Christopher Van Besien

Christopher Van Besien

Aeglea Biotherapeutics
Clinical Project Manager
Austin, Texas
Aeglea is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism and cancer. The company’s engineered human enzymes are designed to degrade specific amino acids in the blood in order to reduce toxic levels of amino acids in inborn errors of metabolism or to exploit the dependence of certain cancers on specific amino acids.

Prior to joining Aeglea, Mr. Van Besien served in project management and data management roles at several leading Clinical Research Organizations. He is a dedicated pharmaceutical and biotechnology research and development professional with over 17 years of experience managing project teams developing programs with specific experience in Neuroscience, Cardiovascular, Ophthalmology, Endocrinology, Oncology and Rare Disease. He has additional experience contributing to early research teams with behavioral pharmacology efforts while at Johnson & Johnson and Amgen. Christopher holds an B.S. in Pharmacology and Toxicology and a Pharmaceutical and Healthcare Business MBA from the University of the Sciences in Philadelphia, PA. Additionally, he pursuing a Master’s in Jurisprudence (MSJ) with a Dual Concentration in Intellectual Property Law and Pharmaceutical & Medical Device Law and Compliance.
Sunday, June 18
 

8:00am CDT

8:30am CDT

12:00pm CDT

1:00pm CDT

2:45pm CDT

4:15pm CDT

 
Monday, June 19
 

8:30am CDT

10:00am CDT

10:15am CDT

11:00am CDT

12:30pm CDT

1:15pm CDT

2:00pm CDT

3:00pm CDT

4:45pm CDT

5:30pm CDT

 
Tuesday, June 20
 

8:00am CDT

9:30am CDT

9:45am CDT

10:30am CDT

12:00pm CDT

12:45pm CDT

1:00pm CDT

1:15pm CDT

2:00pm CDT

4:00pm CDT

 
Wednesday, June 21
 

8:00am CDT

9:30am CDT

9:45am CDT

10:30am CDT

12:00pm CDT

1:00pm CDT

2:00pm CDT

3:15pm CDT

4:00pm CDT

 
Thursday, June 22
 

9:00am CDT

10:45am CDT